Clark Capital Management Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-148,075
| Closed | -$5.5M | – | 428 |
|
|
2024
Q4 | $5.5M | Sell |
148,075
-5,672
| -4% | -$211K | 0.04% | 189 |
|
|
2024
Q3 | $7.46M | Buy |
153,747
+56,337
| +58% | +$2.73M | 0.05% | 163 |
|
|
2024
Q2 | $3.9M | Buy |
97,410
+57,346
| +143% | +$2.29M | 0.03% | 192 |
|
|
2024
Q1 | $1.76M | Sell |
40,064
-22,178
| -36% | -$974K | 0.01% | 256 |
|
|
2023
Q4 | $3.85M | Buy |
62,242
+4,237
| +7% | +$262K | 0.03% | 187 |
|
|
2023
Q3 | $2.67M | Buy |
58,005
+23,373
| +67% | +$1.07M | 0.03% | 195 |
|
|
2023
Q2 | $1.99M | Buy |
+34,632
| New | +$1.99M | 0.02% | 216 |
|
|
2022
Q3 | – | Sell |
-68,957
| Closed | -$2.4M | – | 339 |
|
|
2022
Q2 | $2.4M | Sell |
68,957
-26,672
| -28% | -$928K | 0.03% | 197 |
|
|
2022
Q1 | $3.43M | Buy |
95,629
+15,535
| +19% | +$558K | 0.04% | 204 |
|
|
2021
Q4 | $1.87M | Buy |
+80,094
| New | +$1.87M | 0.02% | 222 |
|